Skip to main content
Equibles
XRAY logo

XRAY · DENTSPLY SIRONA Inc. · Metrics

Track XRAY — free

Use XRAY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XRAY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.87 +0.45 (+5.34%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.72B
Shares
199.35M
Volume · Oct 20 6.14M Avg daily vol (3M) 4.66M

XRAY metrics

103 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.87
Market cap
$1.72B

Price action

20 metrics
Price change (1W)
-1.3%
Price change (30D)
-10.8%
Price change (3M)
-37.4%
Price change (6M)
-34.2%
Price change (YTD)
-26.3%
Price change (1Y)
-32.7%
Trailing year
Price change (5Y)
-85.4%
52-week high
$14.68
52-week low
$8.42
Change from 52-week high
-42.6%
Change from 52-week low
+0.0%
Annualized volatility
47.3%
Annualized volatility (3M)
44.7%
Beta
1.2
RSI (14D)
34.2
Price vs SMA 50
-16.3%
Price vs SMA 200
-26.5%
Avg volume (3M)
4.64M
Relative volume
0.9
Average dollar volume
$50.18M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
199.35M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.0×
reciprocal yield 99.4%
EV / EBITDA
94.0×
reciprocal yield 1.1%
EV / EBIT
—
P / sales
0.5×
reciprocal yield 216.8%
P / book
1.2
reciprocal yield 80.4%
FCF yield
8.5%
TTM · current market cap
Buyback yield
0.7%
P / FCF
11.8
reciprocal yield 8.5%
P / operating cash flow
5.3
reciprocal yield 19.0%
Earnings yield
-32.4%

Historical valuation

8 metrics
P / E historical average (3Y)
53.4×
reciprocal yield 1.9%
P / E historical average (5Y)
53.4×
reciprocal yield 1.9%
EV / revenue historical average (3Y)
1.6×
reciprocal yield 62.6%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 54.5%
EV / EBIT historical average (3Y)
119.2×
reciprocal yield 0.8%
EV / EBIT historical average (5Y)
119.2×
reciprocal yield 0.8%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.9%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.16
Dividend growth YoY
-75.0%
Dividend growth streak
0
Last ex-dividend
2025-12-26

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
49.5%
Operating margin
-8.5%
Trailing 12 months
Net margin
-15.0%
Gross profit (TTM)
$1.80B
Operating profit (TTM)
−$310.00M
Net income (TTM)
−$545.00M
Trailing 12 months
Diluted EPS (TTM)
$-2.75
FCF margin
3.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$18.24
Gross profit per diluted share (TTM)
$9.03
Operating profit per diluted share (TTM)
$-1.56
EBITDA per diluted share (TTM)
$0.19
Net income per diluted share (TTM)
$-2.73
Operating cash flow per diluted share (TTM)
$1.60
Free cash flow per diluted share (TTM)
$0.72
Capital expenditures per diluted share (TTM)
$0.88
R&D per diluted share (TTM)
$0.83
Stock compensation per diluted share (TTM)
$0.16
Book value per share
$6.71

Growth

11 metrics
Revenue growth YoY
-4.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.64B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
-2.1%
Revenue CAGR (5Y)
+2.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-34.4%
FCF CAGR (5Y)
-28.6%

Quality

14 metrics
Return on equity
-40.3%
Return on assets
-10.5%
Debt / equity
1.6
Current ratio
1.6
EBITDA (TTM)
$39.00M
Free cash flow (TTM)
$143.00M
Quick ratio
1.1
Interest coverage
-3.4
Net debt / EBITDA
50.9
Return on invested capital
—
Trailing 12 months
Net cash
−$1.99B
Latest balance sheet
Cash & equivalents
$239.00M
Total assets
$5.20B
Total debt
$2.22B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$319.00M
Capital expenditures (TTM)
$176.00M
R&D (TTM)
$166.00M
SG&A (TTM)
$1.45B
Stock compensation (TTM)
$31.00M
R&D / revenue
4.6%
Stock compensation / revenue
0.9%

Ownership (13F)

9 metrics
13F filers
378
13F filer change QoQ
-8
Institutional ownership
113.7%
Conviction holders (share of 13F filers)
1.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.0%
Holder tenure
13.5
Price vs estimated holder cost
-34.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
23.3%

Short interest

3 metrics
Short interest
12.8%
Latest settlement · 4.5 days to cover
Days to cover
4.5d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 818479 CUSIP 24906P109 13F (30d) 44 filings 43 filers Visit website Investor relations